Evidence map›Paper›PMID 18224337›Full record

Trial reportHuman genetics2008

A new locus for otosclerosis, OTSC8, maps to the pericentromeric region of chromosome 9.

Insaf Bel Hadj Ali, Melissa Thys, Najeh Beltaief, Isabelle Schrauwen, Nele Hilgert, Kathleen Vanderstraeten, Nele Dieltjens, Emna Mnif, Slah Hachicha, Ghazi Besbes and 2 more

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Human genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 60 citations in OpenAlex.

  1. Exploring the genetic landscape of otosclerosis: current understanding and future perspectives.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2025
    Review
  2. Journal of medical genetics · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Genetic Heterogeneity and Core Clinical Features of NOG-Related-Symphalangism Spectrum Disorder.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2021
    Article
  10. Review
  11. Insufficient evidence for a role of SERPINF1 in otosclerosis.Molecular genetics and genomics : MGG · 2019
    Article
  12. Article
  13. Identification of target proteins involved in cochlear otosclerosis.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2015
    Article
  14. Exclusion of TNFRSF11B as Candidate Gene for Otosclerosis in Campania Population.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2014
    Article
  15. Rare variants in BMP2 and BMP4 found in otosclerosis patients reduce Smad signaling.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2014
    Article
  16. The rs39335 polymorphism of the RELN gene is not associated with otosclerosis in a southern Italian population.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2013
    Article
  17. Article
  18. Cochlear otosclerosis.Current opinion in otolaryngology & head and neck surgery · 2010
    Review
  19. Etiopathogenesis of otosclerosis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2010
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Insaf Bel Hadj AliUnité d'Epidémiologie Génétique et Moléculaire, Faculté de Médecine, 1007, Tunis, Tunisia.
Melissa Thys
Najeh Beltaief
Isabelle Schrauwen
Nele Hilgert
Kathleen Vanderstraeten
Nele Dieltjens
Emna Mnif
Slah Hachicha
Ghazi Besbes
Saïda Ben Arab
Guy Van Camp
University of Antwerp · BEHôpital La Rabta · TN

Funding

Otosclerosis-A Molecular Genetic StudyR01DC005218 · NIDCD · UNIVERSITY OF IOWA · PI SMITH, RICHARD J. H. · 2002 to 2006
$1.5M
NIDCD NIH HHS R01DC05218
6 · The paper itself

Abstract

Otosclerosis is a common disorder of the otic capsule resulting in hearing impairment in 0.3-0.4% of the Caucasian population. The aetiology of the disease remains unclear. In most cases, otosclerosis can be considered as a complex disease. In some cases, the disease is inherited as an autosomal dominant trait, sometimes with reduced penetrance. To date, seven autosomal dominant loci have been reported, but none of the disease-causing genes has been identified. In this study, we present the results of a genome-wide linkage analysis in a large Tunisian family segregating autosomal dominant otosclerosis. Linkage analysis localised the responsible gene to chromosome 9p13.1-9q21.11 with a maximal LOD score of 4.13, and this locus was named OTSC8. Using newly generated short tandem repeat polymorphism markers, we mapped this new otosclerosis locus to a 34.16 Mb interval between the markers D9S970 and D9S1799. This region comprises the pericentromeric region on both arms of chromosome 9, a highly complex region containing many duplicated sequences.

Indexed as

AdolescentAdultAgedCentromereChromosome MappingChromosomes, Human, Pair 9FemaleGenes, DominantGenetic LinkageGenetic MarkersGenotypeHaplotypesHumansLod ScoreMaleMiddle AgedGenetic Markers

Identifiers

PMID18224337
OpenAlexW1980867768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.